China’s Innovent Biologics secures over $300 million investment from Sanofi
The all-cash investment by Sanofi unit Sanofi Foreign Participations BV will be at a price of $42.42 per Innovent share,…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Innovent Biologics
US FDA grants Orphan Drug Designation to BCMA CAR-T cell therapy co-developed by Innovent Biologics…
ODD will accelerate drug development and registration action in the US
Innovent and Eli Lilly announce final clinical results and biomarker analysis of phase-Ib study of…
The Overall Response Rate (ORR) was 34 per cent (17/50) and ORRs for the low-dose and high-dose groups were 31 per cent and 38 per…